MC
LLY icon

Mirabaud & Cie’s Eli Lilly LLY Stock Holding History

Mirabaud & Cie’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Sell
2,951
-4,513
-60% -$4.61M 1.42% 15
2026
Q1 		$6.87M Sell
7,464
-5,039
-40% -$5.11M 2.79% 9
2025
Q4 		$13.4M Sell
12,503
-192
-2% -$184K 4.33% 8
2025
Q3 		$9.69M Buy
12,695
+350
+3% +$260K 3.08% 10
2025
Q2 		$9.62M Buy
12,345
+6,658
+117% +$5.17M 3.06% 10
2025
Q1 		$4.7M Buy
+5,687
New +$4.73M 1.6% 17

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mirabaud & Cie's LLY Position: Q2 2026 in Review

Mirabaud & Cie reduced its Eli Lilly (LLY) stake by 60% in Q2 2026, selling an estimated $4.61M and leaving 2,951 shares worth $3.54M. The position accounts for 1.42% of the portfolio, ranked #15.

Mirabaud & Cie first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.4M in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mirabaud & Cie held 2,951 shares of Eli Lilly worth $3.54M as of Q2 2026.
  • Mirabaud & Cie sold 4,513 Eli Lilly shares in Q2 2026, an estimated $4.61M.
  • Eli Lilly made up 1.42% of Mirabaud & Cie's portfolio in Q2 2026, its #15 holding.
  • Mirabaud & Cie first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Mirabaud & Cie's Eli Lilly position peaked at $13.4M in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mirabaud & Cie's 13F filing for Q2 2026, filed 8 Jul 2026.